Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Multi-center, invesitigator-initiated phase 1 study of NY-ESO-1 specific TCR gene transduced T lyphocytes transfuse in patient with refractory adult T-cell leukemia/lymphoma (ATLL) experiencing recurrence after allogenic hematopoietic stem cell transplantation

Trial Profile

Multi-center, invesitigator-initiated phase 1 study of NY-ESO-1 specific TCR gene transduced T lyphocytes transfuse in patient with refractory adult T-cell leukemia/lymphoma (ATLL) experiencing recurrence after allogenic hematopoietic stem cell transplantation

Recruiting
Phase of Trial: Phase I

Latest Information Update: 26 Sep 2018

At a glance

  • Drugs NTBI 1301 (Primary) ; Cyclophosphamide
  • Indications Adult T-cell leukaemia-lymphoma
  • Focus Adverse reactions
  • Most Recent Events

    • 24 Jan 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top